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The gene coding for the clofibrate-induced cytochrome P-452 has been isolated from a cDNA library and a full-length 
cDNA clone sequenced. The sequence was identical with that reported by Hardwick et al. [(1987) J. Biol. Chem. 262, 
801-8101 apart from the presence of an additional 75 nucleotides inserted adjacent to the 3’-end of the coding region. 
Northern blot analysis indicates that this is probably a consequence of differential splicing, which may be relevant to 
the tissue-specific regulation of this gene. 
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1. INTRODUCTION 
The cytochrome P-450 proteins play an impor- 
tant role in the metabolism of endogenous 
substrates, detoxification of drugs and 
xenobiotics, and activation of environmental 
agents to toxic, mutagenic and carcinogenic forms. 
The broad specificity of these systems is due to the 
existence of a large family of related genes [2], the 
expression of each isoenzyme being modulated by 
endogenous factors or by exposure to various 
xenobiotics. This laboratory has already reported 
the purification and characterisation of a unique 
hepatic isoenzyme termed cytochrome P-452 (also 
known as P450 IVAl) induced by the hypo- 
lipidaemic drug clofibrate [3,4]. Unlike other 
cytochrome P-450 variants, this enzyme readily 
metabolises fatty acids but not drugs. Hardwick et 
al. [l] have shown that rat hepatic lauric acid w- 
hydroxylase, or cytochrome P-450 LAW (thought 
to be the same as cytochrome P-452) shares less 
than 35% amino acid homology with cytochromes 
P-450 c,d,e and PCN. Another potential member 
of this new gene family, rabbit pulmonary pros- 
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taglandin w-hydroxylase, cytochrome P-450 p-2, 
has recently been reported [5]. 
The process of induction of cytochrome P-452 is 
of substantial interest in relation to the hepatotox- 
icity of hypolipidaemics [6], Clofibrate administra- 
tion and transcriptional activation of the LAW 
gene in rat liver are closely linked [l] and a similar 
transcriptional activation of the first two perox- 
isomal &oxidation enzymes has been observed in 
liver [7]. The results in this paper indicate a 
heterogeneity in the 3 ‘-non-coding region of 
cytochrome P-452 mRNA which may be relevant 
to the regulation of this gene. 
2. MATERIALS AND METHODS 
2.1. Cloning and sequencing of cytochrome P-452 cDNA 
Clofibrate (400 mg/kg) was administered intraperitoneally to 
a 150 g male Wistar rat. After 16 h, total liver RNA was ex- 
tracted using a guanidine thiocyanate/caesium chloride method 
181. The poly(A+) mRNA was purified and cDNA synthesized 
by standard procedures [9]. EcoRI linkers were added for liga- 
tion with A gtll [lo]. The cDNA library was screened with 
polyclonal antiserum to electrophoretically homogeneous 
cytochrome P-452 [3], using a biotin-streptavidin linked im- 
munoassay system [I 11. DNA sequence analysis was carried out 
by the dideoxy procedure after subcloning into Ml3 vectors. 
Smaller fragments were generated by digestion with specific 
restriction endonucleases (Pstl, MI, Ncol, BamHI) and by pro- 
gressive digestion with BumI nuclease. 
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50 100 
CGCTGCACCATGAGCGTCTCTGCACTGAGCTCCACCCGCTTTCCTCCAAGTGGCCTCCG~GCTTGGTCT~CTTC~GCTGC 
MSVSALSSTRFTGSISGF LQVASVLGLLLL 
150 200 
TGGTCAAAGCAGTCCAGTTCTACCTGCAAAGGCAATGGCTACTCAAGGCTTTCCAGCAGTTCCCATCACCTCCCTTCCACTGGTTCTTTGGGCACAAGCA 
L V K A V Q F Y L Q R Q W L L K A F QQFPSPPFHWFFGHKQ 
250 300 
GTTTCAAGGTGACAAAGAACTACAGCAAATTATGACATGTGTGGAGAATTTCCCAAGTGCCTTTCCTCG~TGGTTCTGG~GAAGCAAAG~CTACTTAAT~ 
FQGDKELQQIMTCVENFPSAFPRWFWGSKAYLI 
350 400 
GTCTATGACCCTGACTACATGAAGGTGATTCTCGGGCGATCAGATCCAAAGGCCAATGGCGTCTACAGATTGCTAGCTCCTTGGATCGGATATGGTTTGC 
"YDPDYMKVILGRSDPKANGVYRLLAPWIGYGL 
450 500 
TCTTGCTGAATGGACAACCGTGGTTCCAGCACCGGCGAATGCTAACCCCAGCCTTCCACTATGACATTCTGAAACCCTATGTAAAAAACATGGCTGACTC 
L L L N G QPWFQHRRMLTPAFHYDILKPYVKNMADS 
550 600 
CATTCGACTGATGCTAGACAAATGGGAACAGCTGGCAGGTCAAGACTCCTCTATAGAAATCTTTCAACATATCTCCTTAATGACCCTAGACACTGTCATG 
IRLMLDKWEQLAGQDSSIEIFQRISLMTLDTVM 
650 700 
AAGTGTGCCTTCAGCCACAATGGCAGTGTTCAGGTGGATGGAAATTACAAGAGCTATATCCAGGCCATTGGGAACTTGAATGACCTCTTTCACTCCCGTG 
KCAFSHNGSVQVDGNYKSYIQAIGNLNDLF"SR 
750 800 
TGAGGAACATCTTTCATCAGAATGATACCATCTATAATTTTTCTTCCAATGGCCACTTGTTCAACCGTGCTTGTCAACTTGCCCATGATCACACAGATGG 
VRNIFHQNDTIYNFSSNGHLFNRAC Q L A H D H T D G 
850 -> 
TGTGATCAAGCTAAGGAAGGATCAGCTGCRGAATGCGGGAGAGCTGGAAAAGGTCAAGA~GAAAAGACG~TTGGATTTTCTGGACATCC~CTTACTTGCC 
VIKLRKD QLQNAGELEKVKKKRRLDFLDILLLA 
950 1000 
AGAATGGAGAATGGGGACAGCTTGTCTGACAAGGACCTACGTGCTGAGGTGGACACATTTATGTTCGAGGGTCATGACACCACAGCCAGTGGAGTCTCCT 
RMENGDSLSDKDLRAEVDTFMFEGHDTTAS G V S 
G 1050 1100 
GGATCTTCTATGCTCTGGCCACACACCCTAAGCACCAACAAAGATGCAGAGAGGAAGTTCAGAGTGTCCTGGGGGATGGGTCCTCCATTACCTGGGATCA 
WIFYALATHPKH QQRCREEVQSVLGDGSSITWD" 
.C 1150 1200 
CCTGGACCAGATTCCCTACACCACCATGTGTATCAAGGA~GCCCTGAGGCTTTACCCACCTGTTCCAGG~ATTGTCAGAGAACTCAGCACATCTGTCACC 
LDQIPYTTMCIKEALRLYPPVPGIVRELSTSVT 
1250 1300 
TTCCCTGATGGGCGCTCTTTACCCAAGGGTATCCAAGTCACACTCTCCATTTATGGTCTCCACCACAACCCGAAGGTGTGGCCAAACCCAGAGGTGTTTG 
FPDGRSLPKGIQVTLSIYGLHHNPKVWPNPEVF 
1350 1400 
ACCCTTCCAGGTTTGCACCAGACTCTCCCCGACACAGCCACTCATTCCTGCCCTTCTCAGGAGGAGCGAGGAACTGCATTGGGAAACAATTTGCTATGAG 
DPSRFAPDSPRHSHSFLPFSGGARNCIGKQFAMS 
.CG 1450 1500 
TGAGATGAAGGTGATTGTGGCCCTGACCCTGCTCCGCTTTGAGCTACTGCCAGATCCCACCAAGGTCCCCATCCCCTTACCACGACTTGTGCTGAAGTCC 
EMKVIVALTLLRFELLPDPTKVPIPLPRLVLKS 
1550 1600 
AAAAATGGGATCTACCTGTATCTCAAGAAGCTCCACTAATTCCGGACTTCTTCATTATACCAATAATCAACGGTCACAACCTTGATGGTCGGGAATAACA 
KNGIYLYLKKLH' --_--_-__________-_----_-_______________________________ 
1650 1700 
GGACGTTATTATCTTACAGTTGTGGAGCTCCGAAATCTGAAATGAGTTTCACTGGCAGAAAGCTGAGTTGGTGGTGTGACTAGCCTTCTTCAGAAGAGTG 
___________________ 
1750 1800 
CTTCAGAGAGTCCTCTCCTCCTCTCTTCAGTACAGATCACCCTTCTCAGCACTGGAATATTCCTCTGCTTTAAAGCCAGCACCCTTCCCATACCCCCTCT 
1850 1900 
TCTAAAAGCCTTCCCTTTTACAAATGTTCTTATGACATCATCAAGACCACTGAAAAACTCCAAGATAATTTCCCATCTCAATATTCCTTACTCCATCTAA 
1950 2000 
CCTACTAAGTCCCTTTTGAATTATGAGGAATAATTCAATTTGTTCCATGGGCTCCAAAACTCAAGGCCTGAGCATTATTGTGAAACCTTTATTCAGCCTA 
2050 2100 
ATATCATCTTCACAAGACTGTTACCTGGTACGTTCATCTAAATCTCCCCTGCATAGTCTCTCTACCTGACTATTCCTCACACAAGTTTCTTTACCTTCCC 
A 2150 
TCCTTTCTCCAATAAAGTGTCCAGTGTCCTGCACAAAAAAAAAAAAAAAAAAAAAAA 
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2.2. Oligonucleotide probes and hybridisations 
Oligonucleotides were kindly synthesized by C. Entwistle, 
and were 5’-labelled with 32P using T4 polynucleotide kinase 
(Amersham). Other probes were labelled with [3ZP]dATP using 
an Amersham ‘Multiprime’ kit. After electrophoresis, RNA 
was transferred to Pall Biodyne membranes [12]. With the 
cDNA probe, the filters were pre-hybridised (50% formamide, 
5 x SSC, 25 mM sodium phosphate, pH 6.5, 10 x Denhardt’s 
solution, 200 pg/ml sonicated denatured herring testes DNA) at 
42°C for 3 h; hybridisation was then carried out overnight at 
the same temperature. The filters were washed in 2 x SSC, 
0.1% SDS and then in 0.5 x SSC, 0.1% SDS (all at 50°C) prior 
to autoradiography at - 70°C. Hybridisation with 
oligonucleotide probes was at 55°C in a mixture of 6 x SSC, 
10 x Denhardt’s solution, 0.2% SDS and 100 pg/ml sonicated 
denatured herring testes DNA. Filters were washed at room 
temperature in 0.1 x SSC plus 0.1% SDS, and then in 2 x SSC 
containing 0.1% SDS at 50°C. 
3. RESULTS AND DISCUSSION 
Screening of the clofibrate-induced rat liver 
cDNA library with monospecific polyclonal an- 
tiserum yielded several positive clones. The largest 
insert (1.2 kb; clone gt 11-A) was labelled and used 
to rescreen the library, yielding a clone (gtll-B) 
with an insert of 2.1 kb. This clone, from a 
previous Northern blot analysis (not shown), must 
contain a virtually full-length cDNA. 
The cDNA inserts from gt 11 -A and gt 11 -B were 
sequenced. Fig.1 shows the sequence from the 
presumed full-length clone gtl l-B. The sequence 
of the coding region is identical to that of Hard- 
wick et al. [l], thus confirming that cytochrome 
P-452 is identical to cytochrome P-450 LAW. With 
the partial cDNA clone (A) four base differences 
were found which may arise from reverse 
transcriptase infidelity in the construction of this 
clone. 
A more significant discrepancy was found in the 
3 ’ -non-coding region. Although clone A was iden- 
tical to P-45OLAw throughout this region, clone B 
possessed an additional 75 nucleotides shortly after 
the terminating codon (1545-1619, fig.l). The 
significance of this sequence was investigated by 
Northern blots with a P-452 cDNA probe and two 
synthetic 20-mer oligonucleotides (fig.2). Probe 1 
is complementary to the 3 ‘-end of the coding 
region, which is the same in both clones A and B, 
Fig.2. Sequence of ohgonucleotide probes. Oligonucleotide 
probes were synthesized, complementary to the indicated 
(underlined) regions of the DNA sequence of clone gtll-B. 
Probe 1 was complementary to the sequence from 1525 to 1544, 
while probe 2 was complementary to bases 1571-1590: The 
sequence from 1545 to 1619, indicated by a broken line, 
represents the additional 75 base sequence present only in 
gtll-B. (*) Stop codon. 
and should therefore detect both mRNA species 
(and possibly others not yet identified). Probe 2 is 
complementary to part of the 75 nucleotide insert 
and is thus specific for the insert sequence. This 
was confirmed by dot hybridisations with the two 
clones. 
The P-452 cDNA probe (fig.3A) showed the 
presence of low levels of mRNA in untreated 
kidney and liver and a marked increased after 
clofibrate administration. The two synthetic pro- 
r-a - + -+-+ _.I._& 
Fig.3. Northern blot analysis of cytochrome P-452 mRNA. 
25 pg of total RNA isolated from liver or kidney from control 
(-) or clofibrate treated (+) rats was electrophoresed on 1.2% 
denaturing (formaldehyde) agarose gels and transferred to 
nylon filters. The probes were ‘*P-labelled P-452 cDNA derived 
from clone gtll-B (A), or oligonucleotides 1 and 2 (B,C, 
respectively). Autoradiography was for 40 h. Ribosomal RNA 
size markers were used, as indicated. 
Fig. 1. Sequence of cytochrome P-452 as found in clone gtl l-B. The arrow at position 899 indicates the 5 ‘-end of the partial clone 
gt 11-A. The isolated bases above the DNA sequence show the differences in the sequence determined for clone A. The sequence from 
1545 to 1619, indicated by a broken line, is only present in gtll-B. (*) Stop codon. 
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Fig.4. Potential stem-loop structures. Structures 1 and 2 are 
predicted in the mRNA corresponding to clone A. The 
arrowhead indicates the position of the 75 base insert in clone 
B. In the mRNA corresponding to clone B, structure 1 will be 
replaced by structure 3. The UAA stop codon is indicated by 
underlining; the numbering of all three structures is according 
to the sequence of clone B. 
bes (fig.3B,C) detected a mRNA species of similar 
size that was present at a very low level in the con- 
trol tissue and was dramatically induced by 
clofibrate. This establishes that mRNA containing 
the 75 nucleotide insert is present in the tissue and 
is induced by clofibrate. Therefore the presence of 
this sequence in clone B is not the result of a clon- 
ing artefact . 
One possible explanation for this heterogeneity 
is that there are two almost identical copies of the 
gene, one of which has the extra 75 nucleotides ad- 
jacent to the termination codon. However, 
Southern blot analysis of rat genomic DNA digests 
using oligonucleotide 1 (which is common to both 
sequences) detects only a single band (not shown), 
which is consistent with the existence of a single 
gene. 
A more likely explanation is that differential 
splicing of an intron can occur in the 3 ‘-non- 
coding region. This intron would have a single 
5 ‘-splice donor site corresponding to position 1544 
(fig.1) and two alternative 3’-splice acceptors. One 
of these, corresponding to position 1619 in fig.1, 
would give rise to the sequence seen in clone A, 
while the other acceptor site, at a position 75 
nucleotides upstream, results in the gtll-B se- 
quence which includes the 75 base insert. This is 
360 
supported by the presence at 1619 of a canonical 
splice acceptor site TCTTACAG (fig. 1). 
Alternative RNA splicing has previously been 
shown for a human cytochrome P-450 [13]; this 
was within the coding region and the alternative 
mRNA did not appear to code for a functional 
protein. The results presented here are distinct in 
that the differential splicing occurs in the 3 ‘-non- 
coding region, so both forms of the mRNA can 
code for a functional product. Differential splicing 
may however play a role in the regulation of gene 
expression. Analysis of the 3 ’ -non-coding regions 
shows that different stem-loop structures are to be 
expected in the two forms of mRNA (fig.4). Such 
structures in the 3 ‘-non-coding region have been 
reported to affect mRNA stability [14] or transla- 
tional repression [ 151. The biological significance 
of this phenomenon and its possible relevance to 
the control of expression of this gene is the subject 
of further investigations. 
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